Advertisement
Advertisement

Read Now: TheBodyPRO.com Covers AIDS 2014

Aging With Complex Chronic Disease: The Wrinkled Face of AIDS

June 2010

 < Prev  |  1  |  2  |  3 

References

  1. Deeks SG. Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy. Top HIV Med 2009; 17(4):118-123.

  2. Deeks SG, Phillips AN. HIV infection, antiretroviral treatment, aging, and non-AIDS related morbidity. BMJ 2009; 338:a3172.

  3. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 2008; 372(9635):293-299.

  4. Sterne JA, May M, Costagliola D et al. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 2009; 373(9672):1352-1363.

  5. Kitahata MM, Gange SJ, Abraham AG et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009; 360(18):1815-1826.

  6. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Reports 2007. Department of Health and Human Services. 11-10-2009. Ref Type: Electronic Citation

  7. Effros RB, Fletcher CV, Gebo K et al. Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis 2008; 47(4):542-553.

  8. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Reports 2007. Department of Health and Human Services. 11-10-2009. Ref Type: Electronic Citation

  9. Ostrow DG, Plankey MW, Cox C et al. Specific sex drug combinations contribute to the majority of recent HIV seroconversions among MSM in the MACS. J Acquir Immune Defic Syndr 2009; 51(3):349-355.

  10. Cook R, McGinnis K, Samet J et al. Erectile Dysfunction Drug Receipt, Risky Sexual Behavior and Sexually Transmitted Diseases in HIV-infected and HIV-uninfected Men. Journal of General Internal Medicine. In press.

  11. Hallfors DD, Iritani BJ, Miller WC, Bauer DJ. Sexual and drug behavior patterns and HIV and STD racial disparities: the need for new directions. Am J Public Health 2007; 97(1):125-132.

  12. D'Arminio MA, Sabin CA, Phillips A et al. The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy. Arch Intern Med 2005; 165(4):416-423.

  13. Mocroft A, Sterne JA, Egger M et al. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal. Clin Infect Dis 2009; 48(8):1138-1151.

  14. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 2008; 372(9635):293-299.

  15. Silverberg MJ, Leyden W, Horberg MA, DeLorenze GN, Klein D, Quesenberry CP, Jr. Older age and the response to and tolerability of antiretroviral therapy. Arch Intern Med 2007; 167(7):684-691.

  16. Goulet JL, Fultz SL, Rimland D et al. Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? Clin Infect Dis 2007; 45(12):1593-1601.

  17. Palella FJ, Jr., Baker RK, Moorman AC et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006; 43(1):27-34.

  18. Smit C, Geskus R, Walker S et al. Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion. AIDS 2006; 20(5):741-749.

  19. Lohse N, Hansen AB, Pedersen G et al. Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med 2007; 146(2):87-95.

  20. Justice AC. Commentary: Treated HIV infection is a chronic disease: the case against cause of death analyses. Int J Epidemiol 2009.

  21. Goulet JL, Fultz SL, Rimland D et al. Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? Clin Infect Dis 2007; 45(12):1593-1601.

  22. McGinnis KA, Fultz SL, Skanderson M, Conigliaro J, Bryant K, Justice AC. Hepatocellular carcinoma and non-Hodgkin's lymphoma: the roles of HIV, hepatitis C infection, and alcohol abuse. J Clin Oncol 2006; 24(31):5005-5009.

  23. Justice AC, Lasky E, McGinnis KA et al. Medical disease and alcohol use among veterans with human immunodeficiency infection: A comparison of disease measurement strategies. Med Care 2006; 44(8 Suppl 2):S52-S60.

  24. Silverberg MJ, Chao C, Leyden WA et al. HIV infection and the risk of cancers with and without a known infectious cause. AIDS 2009; 23(17):2337-2345.

  25. Bedimo RJ, McGinnis KA, Dunlap M, Rodriguez-Barradas MC, Justice AC. Incidence of Non-AIDS-Defining Malignancies in HIV-Infected Versus Noninfected Patients in the HAART Era: Impact of Immunosuppression. J Acquir Immune Defic Syndr 2009.

  26. Crothers K, Goulet JL, Rodriguez-Barradas MC et al. Impact of cigarette smoking on mortality in HIV-positive and HIV-negative veterans. AIDS Educ Prev 2009; 21(3 Suppl):40-53.

  27. Crothers K, Butt AA, Gibert CL, Rodriguez-Barradas MC, Crystal S, Justice AC. Increased COPD among HIV-positive compared to HIV-negative veterans. Chest 2006; 130(5):1326-1333.

  28. Justice AC, Zingmond DS, Gordon KS et al. Drug toxicity, HIV progression, or comorbidity of aging: does tipranavir use increase the risk of intracranial hemorrhage? Clin Infect Dis 2008; 47(9):1226-1230.

  29. Triant VA, Brown TT, Lee H, Grinspoon SK. Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system. J Clin Endocrinol Metab 2008; 93(9):3499-3504.

  30. Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS 2006; 20(17):2165-2174.

  31. Klein D, Hurley LB, Quesenberry CP, Jr., Sidney S. Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection? J Acquir Immune Defic Syndr 2002; 30(5):471-477.

  32. Currier JS, Taylor A, Boyd F et al. Coronary heart disease in HIV-infected individuals. J Acquir Immune Defic Syndr 2003; 33(4):506-512.

  33. Rickerts V, Brodt H, Staszewski S, Stille W. Incidence of myocardial infarctions in HIV-infected patients between 1983 and 1998: the Frankfurt HIV-cohort study. Eur J Med Res 2000; 5(8):329-333.

  34. Mary-Krause M, Cotte L, Simon A, Partisani M, Costagliola D. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men. AIDS 2003; 17(17):2479-2486.

  35. Butt AA, Xiaoqiang W, Budoff M, Leaf D, Kuller LH, Justice AC. Hepatitis C virus infection and the risk of coronary disease. Clin Infect Dis 2009; 49(2):225-232.

  36. Butt AA, McGinnis K, Rodriguez-Barradas MC et al. HIV infection and the risk of diabetes mellitus. AIDS 2009; 23(10):1227-1234.

  37. Egger M, Junghans C, Friis-Moller N, Lundgren JD. Highly active antiretroviral therapy and coronary heart disease: the need for perspective. AIDS 2003; 15 (suppl 5):s193-s201.

  38. Pol S, Lamorthe B, Thi NT et al. Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users. Journal of Hepatology 1998; 28(6):945-950.

  39. Prakash O, Mason A, Luftig RB, Bautista AP. Hepatitis C virus (HCV) and human immunodeficiency virus type 1 (HIV-1) infections in alcoholics. Frontiers in Bioscience 2002; 7:e286-e300.

  40. El-Sadr WM, Lundgren JD, Neaton JD et al. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 2006; 355(22):2283-2296.

  41. Gill TM. Geriatric medicine: it's more than caring for old people. Am J Med 2002; 113(1):85-90.

  42. Panel on Clinical Practices for Treatment of HIV Infection. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. 1-97. 4-7-2005. Washington, DC, Department of Health and Human Services/ Henry J. Kaiser Family Foundation. Ref Type: Report

  43. El-Sadr WM, Lundgren JD, Neaton JD et al. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 2006; 355(22):2283-2296.

  44. Tinetti ME, Fried T. The end of the disease era. Am J Med 2004; 116(3):179-185.

  45. Walston J, Hadley EC, Ferrucci L et al. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/ National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc 2006; 54(6):991-1001.

  46. Tinetti ME, Bogardus ST, Jr., Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med 2004; 351(27):2870-2874.

  47. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005; 294(6):716-724.

  48. Goulet JL, Fultz SL, Rimland D et al. Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? Clin Infect Dis 2007; 45(12):1593-1601.

  49. Lee SJ, Lindquist K, Segal MR, Covinsky KE. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 2006; 295(7):801-808.

  50. Boyd CM, Weiss CO, Halter J, Han KC, Ershler WB, Fried LP. Framework for evaluating disease severity measures in older adults with comorbidity. J Gerontol A Biol Sci Med Sci 2007; 62(3):286-295.

  51. Walston J, Hadley EC, Ferrucci L et al. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/ National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc 2006; 54(6):991-1001.

  52. Desquilbet L, Jacobson LP, Fried LP et al. HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci 2007; 62(11):1279-1286.

  53. Desquilbet L, Jacobson LP, Fried LP et al. HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci 2007; 62(11):1279-1286.

  54. Gill TM. Geriatric medicine: it's more than caring for old people. Am J Med 2002; 113(1):85-90.

  55. Oursler KK, Goulet JL, Leaf DA et al. Association of comorbidity with physical disability in older HIV-infected adults. AIDS Patient Care STDS 2006; 20(11):782-791.

  56. Oursler KK, Sorkin JD, Smith BA, Katzel LI. Reduced aerobic capacity and physical functioning in older HIV-infected men. AIDS Res Hum Retroviruses 2006; 22(11):1113-1121.

  57. Phillips AN, Neaton J, Lundgren JD. The role of HIV in serious diseases other than AIDS. AIDS 2008; 22(18):2409-2418.

  58. Justice AC, McGinnis KA, Skanderson M et al. Towards a combined prognostic index for survival in HIV infection: the role of "non-HIV" biomarkers. HIV Med 2009.
 < Prev  |  1  |  2  |  3 



This article was provided by Gay Men's Health Crisis. It is a part of the publication GMHC Treatment Issues. Visit GMHC's website to find out more about their activities, publications and services.
 

 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Advertisement